|Articles|July 10, 2015

Rep. Frank Pallone Jr. Discusses the NIH Innovation Fund

Rep. Frank Pallone Jr., Sixth Congressional District of New Jersey, House Energy and Commerce Committee, provides an overview of the National Institutes of Health (NIH) Innovation Fund.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!

Related Content

Real-Time Text Tool Tracks Quality of Life in Myeloma Care

ByDr. James Berenson

December 7th 2025

Dr. Thomas Marron explains how therapeutic vaccines differ from preventative vaccines in lung cancer care.

How Therapeutic Vaccines May Transform Lung Cancer Care

ByDr. Thomas Marron

December 5th 2025

How Bispecific Antibodies Work to Treat Patients With Multiple Myeloma

ByDr. Amany Keruakous

December 5th 2025

Dr. Ajay Gupta of the Roswell Park Comprehensive Cancer Center discussed basics of gastrointestinal stromal tumors.

Essential Insights on GIST and Gleevec for Patients

ByDr. Ajay Gupta

December 5th 2025

Dr. Daniel Peters discussed targeted therapies and regimens that patients with acute myeloid leukemia, or AML, should be aware of.

What Patients With AML Need to Know About Azacitidine and Venclexta

ByDr. Daniel Peters

December 5th 2025

Rep. Frank Pallone Jr. Discusses the NIH Innovation Fund

Newsletter

Related Content

Real-Time Text Tool Tracks Quality of Life in Myeloma Care

How Therapeutic Vaccines May Transform Lung Cancer Care

How Bispecific Antibodies Work to Treat Patients With Multiple Myeloma

Essential Insights on GIST and Gleevec for Patients

What Patients With AML Need to Know About Azacitidine and Venclexta

Trending on CURE

Every FDA Oncology Approval From November 2025

Azacitidine Plus Venclexta Superior to Chemo in Acute AML

KRd Improves Progression in Newly Diagnosed Patients With Myeloma

Elrexfio Maintains Responses in Elderly, Frail Patients With Multiple Myeloma

Jaypirca Matches Imbruvica's Effectiveness for CLL, With Hints of Long-Term Benefit